| Date Filed | Type | Description |
| 10/06/2023 |
4
| BERSANI PIETRO (CEO) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 65,600 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Misajon Pamela (Director) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| NAGEL MICHAEL (Director) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 18,000 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Catlin Michael (Director) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
| 10/06/2023 |
4
| Hungerford Brian (CFO) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 21,900 restricted stock units
@ $0 |
|
| 10/03/2023 |
3
| Hungerford Brian (CFO) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 08/10/2023 |
3
| Catlin Michael (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 08/02/2023 |
3
| Misajon Pamela (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 08/15/2022 |
4
| Dahlbeck Scott (Chief of Staff) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Cicchetti Americo (Director) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 183,600 options to buy
@ $0.43, valued at
$78.9k
|
|
| 07/05/2022 |
4
| Tirelli Francis X (Director) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 183,600 options to buy
@ $0.43, valued at
$78.9k
|
|
| 07/05/2022 |
4
| Reeves Karen (Director) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 183,600 options to buy
@ $0.43, valued at
$78.9k
|
|
| 05/25/2022 |
4
| Dahlbeck Scott (Chief Medical Officer) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Exercised 17,240 restricted stock units
@ $0 |
|
| 05/24/2022 |
3
| Tirelli Francis X (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 05/24/2022 |
3
| Reeves Karen (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 10/14/2021 |
3
| Clark Daniel Grant (Interim CFO) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 09/10/2021 |
4
| Chiriva Internati Maurizio (CEO) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Bought 2,800 shares
@ $3.699, valued at
$10.4k
|
|
| 08/02/2021 |
4
| Ryan Michael Charles (See Remarks) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Acquired 50,189 shares
@ $0
Acquired 31,991 restricted stock units
@ $0 |
|
| 07/27/2021 |
3
| Ryan Michael Charles (Chief Technology Officer) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 06/24/2021 |
4
| Rotino Gianluca (CHIEF STRAT & INNOV OFFICER) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 71,985 restricted stock units
@ $0 |
|
| 06/24/2021 |
4
| Nunez Ignacio (CHIEF OPERAT. AND MANUF. OFFI.) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 17,710 restricted stock units
@ $0
Granted 147,038 options to buy
@ $8.47, valued at
$1.2M
|
|
| 06/17/2021 |
3
| Nunez Ignacio (See Remarks) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4/A
| Rotino Gianluca (CSO AND CIO) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Disposed/sold 4,423 options to buy
@ $8.14, valued at
$36k
|
|
| 03/11/2021 |
4/A
| Tontat Tony (CFO AND COO) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Disposed/sold 5,528 options to buy
@ $8.14, valued at
$45k
|
|
| 01/06/2021 |
4
| Rotino Gianluca (See Remarks) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 4,423 options to buy
@ $8.14, valued at
$36k
|
|
| 01/06/2021 |
4
| Tontat Tony (CFO & COO) has filed a Form 4 on Kiromic Biopharma, Inc.|
Txns:
| Granted 5,528 options to buy
@ $8.14, valued at
$45k
|
|
| 10/20/2020 |
3
| Schneider Jerry A. (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 10/20/2020 |
3
| NAGEL MICHAEL (Director) has filed a Form 3 on Kiromic Biopharma, Inc. |
| 10/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|